{"disease":{"id":"postpartum-dvt","name":"postpartum dvt"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04305756","title":"Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery","phase":"NA","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT03965572","title":"Factors and Outcomes Associated With Postpartum Cabergoline Use","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Laniado Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}